RUSSIAN JOURNAL OFCARDIOLOGY, 2018, 4 (156)

Address to the readers

Russ J Cardiol 2018, 4 (156): 5

CLINICAL MEDICINE NEWS

Clinical medicine updates: a review of international news

Russ J Cardiol 2018, 4 (156): 6

ORIGINAL ARTICLES

PROGNOSTIC SIGNIFICANCE OF ENDOTHELIAL DYSFUNCTION MARKERS IN ARTERIAL HYPERTENSION

Podzolkov V. I., Bragina A. E., Druzhinina N. A.

Abstract

RETINOL B INDING PROTEIN AS A MARKER OF CARDIOVASCULAR RISK IN ARTERIAL HYPERTENSION AND OBESITY

Vasyuk Yu. A., Sadulaeva I. A., Yushchuk E. N., Trofimenko O. S., Ivanova S. V.

Abstract

RISK GROUPS FOR PREGNANCY HYPERTENSIVE DISORDERS DEVELOPMENT

Shakhbazova N. A.

Abstract

SPECIFICS OF ARTERIAL HYPERTENSION DEVELOPMENT IN PENITENTIARY STRESS CIRCUMSTANCES

Dyuzheva E. V.1,2, Ponomarev S. B.1

Abstract

THE ROLE OF SYSTEMIC INFLAMMATION IN DECREASE OF ELASTICITY OF MAGISTRAL ARTERIES AND IN PROGRESSION OF ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH SYSTEMIC HYPERTENSION, OBESITY AND TYPE 2 DIABETES

Statsenko M. E., Derevyanchenko M. V.

Abstract

SPECIFICS OF NEUROHUMORAL ACTIVITY AND CLINICAL PRESENTATION OF MASKED ARTERIAL HYPERTENSION IN YOUNG MALES

Lyamina N. P., Kosareva A. V., Tsareva O. E., Senchikhin V. N., Lipchanskaya T. P., Shkrobova N. V.

Abstract

TREATMENT ADHERENCE AND EFFICACY OF ANTIHYPERTENSION TREATMENT IN HYPERTENSIVES IN TYUMENSKAYA OBLAST

Efanov A.Yu.1,2, Petrov I.М.1, Petrova Yu. А.3, Vyalkina Yu. А.1, Pochinok Е. М .1, Sholomov I. F.1, Medvedeva I. V.1, Shalaev S. V.1

Abstract

CLINIC AND PHARMACOTHERAPY

OPTIMAL ORGANOPROTECTION, CONTROL OF B LOOD PRESSURE AND METABOLIC DISORDER WITH THE FIXED COMBINATION OF LISINOPRIL, AMLODIPINE AND ROSUVASTATIN IN SYSTEMIC HYPERTENSION

Nedogoda S. V., Chumachek E. V., Ledyaeva A. A., Tsoma V. V., Salasyuk A. S., Smirnova V. O., Hripaeva V. Yu., Palashkin R. V., Popova E. A.

Abstract

COMPARISON OF INFLUENCE OF VARIOUS REGIMENS OF DRUG INTAKE ON 24 HOUR B LOOD PRESSURE, CENTRAL AORTIC PRESSURE AND VASCULAR WALL STIFFNESS IN SYSTEMIC HYPERTENSION PATIENTS WITH ISCHEMIC STROKE

Skibitsky V. V., Fendrikova A. V., Opolskaya S. V.

Abstract

ADDITIONAL ANGIOPROTECTION AND METABOLIC DISORDERS CORRECTION IN TREATMENT OF ARTERIAL HYPERTENSION PATIENTS REACHED TARGET B LOOD PRESSURE LEVELS, WITH FIXED COMBINATION OF PERINDOPRIL AND INDAPAMIDE

Nedogoda S. V., Ledyaeva A. A., Chumachek E. V., Tsoma V. V., Salasyuk A. S., Smirnova V. O., Khripaeva V. Yu., Palashkin R. V., Popova E. A.

Abstract

COMPARISON OF THE ORIGINAL (PLAVIX) AND GENERIC (CLAPITAX) CLOPIDOGREL ON PLATELET AGGREGATION: OBSERVATIONAL STUDY

Skotnikov А. S.1,2, Sizova Zh. М.1, Baglikov А. N.3, Rozhnova О. G.2, Novitsky N. I.3

Abstract

TAURIN INFLUENCE ON CLINICAL COURSE OF STABLE ANGINA IN POSTINFARCTION CARDIOSCLEROSIS PATIENTS

Vasilieva I. S., Rezvan V. V.

Abstract

OPINION ON A PROBLEM

LIRAGLUTIDE PLEIOTROPIC EFFECT IN CARDIOVASCULAR RISK REDUCTION IN TYPE 2 DIABETES — A MANDATE FOR CARDIOLOGIST AND INTERNIST

Nedogoda S. V.

Abstract

EXPERIMENTAL STUDY

THE ROLE OF GROWTH DIFFERENTIATION FACTOR 11 (GDF11) IN REGULATION OF LIPID METABOLISM AND CARDIOHEMODYNAMIC FUNCTIONS IN ESSENTIAL HYPERTENSION PATIENTS IN MODERATE EFFORT EXERCISES

Guseva Е. S.1,2, Davydov S. О .1,2, Kuznik B. I.1,2, Smolyakov Yu. N. 1, Stepanov А. V.1,2, Fine I. V.3, Magen E.4

Abstract

CLINICAL CASES

FAMILY CASE OF MITRAL VALVE PROLAPSE — IMPACT OF INCREASED LEVEL OF TRANSFORMING GROWTH FACTOR β

Omelchenko M. Yu., Malev E. G., Mitrofanova L. B., Vasina L. V., Zemtsovsky E. V., Nedoshivin A. O.

Russ J Cardiol 2018, 4 (156): 99–101

http://dx.doi.org/10.15829/1560-4071-2018-4-99-101

Key words: mitral valve prolapse, transforming growth factor β.

National Almazov Medical Research Center of the Ministry of Health, Saint-Petersburg, Russia.

MALIGNANT HYPERTENSION WITH PREDOMINANT KIDNEY DAMAGE

Lapochkina N. D.1, Mamedguseyinova S. S.1, Korsakova L. V.2, Vechorko V. I.2, Otarova S. М.1, Gordeev I. G.1

Abstract

HYBRID SURGICAL RECONSTRUCTION OF AORTA DISSECTION MANIFESTED DURING PREGNANCY

Kozlov B. N., Panfilov D. S., Pryakhin A. S., Shipulin V. M.

Abstract

LITERATURE REVIEW

CATESTATIN AS A NOVEL MARKER OF CARDIOVASCULAR RISK IN SYSTEMIC HYPERTENSION

Gubareva E. Yu., Kryukov N. N., Gubareva I. V.

Abstract

Яндекс.Метрика